Home Cart Sign in  
Chemical Structure| 518303-20-3 Chemical Structure| 518303-20-3

Structure of UMI-77
CAS No.: 518303-20-3

Chemical Structure| 518303-20-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

UMI-77 is a selective Mcl-1 SMI inhibitor, binding to the BH3 binding groove of Mcl-1 with Ki of 490 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of UMI-77

CAS No. :518303-20-3
Formula : C18H14BrNO5S2
M.W : 468.34
SMILES Code : O=C(O)CSC1=CC(NS(=O)(C2=CC=C(Br)C=C2)=O)=C3C=CC=CC3=C1O
MDL No. :MFCD03471890
InChI Key :WUGANDSUVKXMEC-UHFFFAOYSA-N
Pubchem ID :992586

Safety of UMI-77

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Mcl-1

    Mcl-1, Ki:490 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T 5 µM 12 hours UMI-77 induces mitophagy without causing mitochondrial damage or apoptosis. PMC7665171
ME4405 cells 4 μM 24 hours To evaluate the apoptosis-inducing effect of UMI-77 on ME4405 cells, results showed that OVAAL overexpression conferred resistance to UMI-77-induced apoptosis. PMC6294934
HCT116 cells 4 μM 24 hours To evaluate the apoptosis-inducing effect of UMI-77 on HCT116 cells, results showed that OVAAL knockdown enhanced UMI-77-induced apoptosis. PMC6294934
BxPC-3 cells 3.4 μM 4 days UMI-77 inhibits BxPC-3 cell growth with IC50 of 3.4 μM PMC4174574
Panc-1 cells 4.4 μM 4 days UMI-77 inhibits Panc-1 cell growth with IC50 of 4.4 μM PMC4174574
MiaPaCa-2 cells 12.5 μM 4 days UMI-77 inhibits MiaPaCa-2 cell growth with IC50 of 12.5 μM PMC4174574
AsPC-1 cells 16.1 μM 4 days UMI-77 inhibits AsPC-1 cell growth with IC50 of 16.1 μM PMC4174574
Capan-2 cells 5.5 μM 4 days UMI-77 inhibits Capan-2 cell growth with IC50 of 5.5 μM PMC4174574
MN9D cells 10 µM 4 hours UMI-77 significantly increased the level of cleaved caspase-3 in MN9D cells and induced cell death. PMC6249233
N2A cells 10 µM 4 hours UMI-77 had no significant effect on the level of cleaved caspase-3 in N2A cells. PMC6249233
AGS cells 8 µM (IC50) 48 hours and 72 hours To evaluate the sensitivity of AGS cells to UMI-77, results showed that AGS cells were more sensitive to UMI-77. PMC11236566
MKN45 cells 125 µM (IC50) 48 hours and 72 hours To evaluate the sensitivity of MKN45 cells to UMI-77, results showed that MKN45 cells were less sensitive to UMI-77. PMC11236566
NB4 cells 15–30 µM 6 hours UMI-77 induced NOXA protein expression within 6 hours and resulted in extensive PARP cleavage in NB4 cells after 12 hours, indicating indirect inhibition of MCL1 through NOXA induction. PMC6385300
Jurkat cells 15–30 µM 6 hours UMI-77 induced NOXA protein expression within 6 hours, indicating indirect inhibition of MCL1 through NOXA induction. PMC6385300
U937 cells 15–30 µM 6 hours UMI-77 induced NOXA protein expression within 6 hours, indicating indirect inhibition of MCL1 through NOXA induction. PMC6385300
HeLa 5 µM 8 hours UMI-77 promotes degradation of mitochondrial proteins without affecting endoplasmic reticulum or cytosolic markers. PMC7665171
HGPS-MSCs 1 μM UMI-77 significantly improved the mitochondrial function of HGPS-MSCs, as evidenced by decreased ROS levels, reduced mitochondrial depolarization, and increased basal and maximal respiration levels. PMC11296130

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
APP/PS1 (C57BL/6) mice APP/PS1 mouse model intraperitoneal injection 10 mg/kg every other day for 4 months UMI-77 significantly improved learning and memory in APP/PS1 mice, reduced Aβ plaques and neuroinflammation, and restored mitochondrial morphology. PMC7665171
Pitx3GFP/+ mice Pitx3GFP/+ mice brain slice culture 10 µM overnight treatment UMI-77 treatment increased the number of cleaved caspase-3 positive cells in brain slices of Pitx3GFP/+ mice, indicating that Mcl1 plays a crucial role in the survival of dopaminergic neurons. PMC6249233
Mice LmnaG608G/G608G mice intragastric administration 20 mg/kg every other day for 5 months UMI-77 restored mitochondrial morphology and function in HGPS mice, reduced aging-related tissue changes (such as loss of collagen fibers in the skin and fibrosis in the aorta, heart, muscles, and spleen), and significantly improved the overall health of the mice, including increased hair and weight, enhanced skeletal muscle strength, spatial working memory, and mobility, and extended the lifespan of the mice. PMC11296130
Mice C57/BL6J mice Intraperitoneal injection 5 mg/kg Once daily for 14 days or 49 days UMI-77 promotes mitophagy in the hippocampus of adult mice, enhances neurogenesis, and prolongs the duration of spatial memory. PMC11183181
BALB/c mice Sepsis-induced acute lung injury model Intraperitoneal injection 7.0 mg/kg Once daily for five days UMI-77 significantly ameliorated histopathological changes in the lungs of mice with sepsis-induced ALI and exerted therapeutic effects by modulating key genes and metabolites. PMC11663390
SCID mice BxPC-3 xenograft model intravenous injection 60 mg/kg 5 days per week for 2 weeks UMI-77 significantly inhibited tumor growth in the BxPC-3 xenograft model PMC4174574

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.14mL

0.43mL

0.21mL

10.68mL

2.14mL

1.07mL

21.35mL

4.27mL

2.14mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories